Amgen, Pfizer, and Celltrion are key players poised for rapid expansion in the biosimilars market in the US.

The entities involved

• Amgen →

  American multinational biopharmaceutical company

  • Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
  • Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05
• Pfizer →

  American multinational pharmaceutical and biotechnology corporation

  • Dave Long trained at Fort Knox after graduating from Boardman High School and later worked for Pfizer.Mon 05:00
  • MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
• Celltrion →

  South Korean biopharmaceutical company

  Nothing else this week.

Related events

• GSK and Amgen are major biopharma players.Sep 8
• Pfizer acquired Biohaven Pharmaceuticals, Seagen, and Arena Pharmaceuticals in transactions dating back to 2022.Jun 27
• Major pharmaceutical companies, including Pfizer, AstraZeneca, and Merck, announced several new partnerships and acquisitions in the oncology sector.Jun 8
• Financial analysts reviewed Biohaven's strategic asset sales and corporate strategy following its acquisition by Pfizer.Aug 26
• Major pharmaceutical companies are part of the ten largest global pharma giants as the industry seeks to weaken drug price negotiation.Aug 26